Evidence map›Paper›PMID 32410117›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2020

Neutrophil function is impaired in paediatric patients with malignancy and may be a useful clinical marker.

J Reiné, K Cooper, A Sewell, J Lyall, C Thorbinson, E Hincks, D M Ferreira, B Pizer, B Morton

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

J ReinéDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.ORCID http://orcid.org/0000-0001-7462-2054
K CooperDepartment of Paediatric Oncology, Alder Hey Children's Hospital, Liverpool, UK.
A SewellDepartment of Paediatric Oncology, Alder Hey Children's Hospital, Liverpool, UK.
J LyallDepartment of Paediatric Oncology, Alder Hey Children's Hospital, Liverpool, UK.
C ThorbinsonDepartment of Paediatric Oncology, Alder Hey Children's Hospital, Liverpool, UK.
E HincksDepartment of Paediatric Oncology, Alder Hey Children's Hospital, Liverpool, UK.
D M FerreiraDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
B PizerDepartment of Paediatric Oncology, Alder Hey Children's Hospital, Liverpool, UK.
B MortonDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK. Ben.Morton@lstmed.ac.uk.

Funding

Amy Laura Fund Reference 8538Impala 16/136/35Wellcome Trust 104936/Z/14/Z
6 · The paper itself

Abstract

purposePatients treated with cytotoxic chemotherapy are at risk of neutropenia, neutropenic fever and neutropenic sepsis. We hypothesised that pre-existing neutrophil function dysfunction may increase susceptibility to neutropenic fever in paediatric patients receiving cytotoxic chemotherapy.

methodsProspective cohort study recruited patients at Alder Hey Children's NHS Foundation Trust, United Kingdom. We measured neutrophil phagocytic function using a validated flow cytometric whole blood phagocytosis assay in paediatric patients (n = 16) with oncological disease before and after chemotherapy in a prospective cohort study. We recruited healthy children as a control comparator (n = 10).

resultsWe found significantly decreased phagocytic function in oncology patients compared to healthy participants. In five patients who developed neutropenic fever, we observed increased pre-dose neutrophil respiratory burst.

conclusionWith further validation, measurement of neutrophil function could potentially be used to personalise appropriate prophylactic antimicrobial administration for patients receiving cytotoxic chemotherapy.

Indexed as

AdolescentBiomarkersChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleNeoplasmsNeutrophilsPhagocytosisProspective StudiesBiomarkersBiomarkerCytotoxic chemotherapyFlow cytometryNeutrophilsPaediatric cancerPhagocytosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.